Let me start by saying that we don't ever, ever trade this type of chart... We only look at charts for trading that are very low risk and BEFORE the bullish action starts.
Here we have INJBTC (Injective Protocol) after really strong bullish action.
Right now resistance is being faced at the 1.618 Fib. Extension level marked with a red dashed-line.
Above this level, we can see additional up (green arrow).
Below this level, we can see a retrace before prices continue to grow.
This project looks really good.
Additional details on the chart (support and resistance levels mapped with Fibs.).
Remember to hit LIKE!
Namaste.
Here we have INJBTC (Injective Protocol) after really strong bullish action.
Right now resistance is being faced at the 1.618 Fib. Extension level marked with a red dashed-line.
Above this level, we can see additional up (green arrow).
Below this level, we can see a retrace before prices continue to grow.
This project looks really good.
Additional details on the chart (support and resistance levels mapped with Fibs.).
Remember to hit LIKE!
Namaste.
➢ FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
➢ FREE Quality Content + New Results
t.me/masteranandatrades/6172
➢ Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
➢ FREE Quality Content + New Results
t.me/masteranandatrades/6172
➢ Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
➢ FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
➢ FREE Quality Content + New Results
t.me/masteranandatrades/6172
➢ Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
➢ FREE Quality Content + New Results
t.me/masteranandatrades/6172
➢ Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Penerbitan berkaitan
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.